Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2021 | 94 | 0.84 | Why? |
| Systems Biology | 2 | 2014 | 320 | 0.47 | Why? |
| Mice, Inbred BALB C | 12 | 2021 | 5814 | 0.37 | Why? |
| Immunoglobulin Fc Fragments | 3 | 2021 | 691 | 0.36 | Why? |
| Mice | 23 | 2021 | 21357 | 0.34 | Why? |
| Antibodies, Neutralizing | 11 | 2021 | 25288 | 0.31 | Why? |
| Host-Pathogen Interactions | 4 | 2021 | 11041 | 0.26 | Why? |
| Viral Vaccines | 7 | 2021 | 7560 | 0.25 | Why? |
| Hydroxylamines | 2 | 2021 | 182 | 0.24 | Why? |
| Cytidine | 2 | 2021 | 219 | 0.23 | Why? |
| Animals | 31 | 2021 | 78931 | 0.23 | Why? |
| Cell Line | 11 | 2021 | 12040 | 0.23 | Why? |
| Mesocricetus | 3 | 2021 | 1847 | 0.22 | Why? |
| SARS Virus | 12 | 2021 | 13021 | 0.21 | Why? |
| Virus Replication | 9 | 2021 | 14331 | 0.21 | Why? |
| Newcastle disease virus | 1 | 2020 | 108 | 0.20 | Why? |
| Ribonucleosides | 1 | 2020 | 95 | 0.20 | Why? |
| Immunoglobulin Variable Region | 1 | 2020 | 253 | 0.19 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2020 | 222 | 0.19 | Why? |
| Antibodies, Viral | 11 | 2021 | 51949 | 0.19 | Why? |
| Encephalomyelitis, Venezuelan Equine | 1 | 2018 | 16 | 0.19 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.18 | Why? |
| Encephalitis Virus, Venezuelan Equine | 1 | 2018 | 71 | 0.18 | Why? |
| RNA Virus Infections | 1 | 2020 | 231 | 0.17 | Why? |
| Disease Models, Animal | 9 | 2021 | 10998 | 0.17 | Why? |
| Peptide Library | 1 | 2020 | 564 | 0.17 | Why? |
| Spike Glycoprotein, Coronavirus | 11 | 2021 | 37182 | 0.17 | Why? |
| Influenza A Virus, H5N1 Subtype | 2 | 2018 | 492 | 0.16 | Why? |
| Reverse Genetics | 1 | 2020 | 439 | 0.16 | Why? |
| Antibodies, Monoclonal | 5 | 2021 | 8041 | 0.16 | Why? |
| Protein Domains | 4 | 2021 | 6563 | 0.15 | Why? |
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 88 | 0.14 | Why? |
| Interferons | 2 | 2020 | 2885 | 0.14 | Why? |
| Genetics | 1 | 2014 | 19 | 0.14 | Why? |
| Gene Expression Regulation, Viral | 1 | 2020 | 925 | 0.14 | Why? |
| Interleukins | 1 | 2020 | 762 | 0.14 | Why? |
| Antigen Presentation | 1 | 2018 | 524 | 0.14 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.14 | Why? |
| Coronavirus Infections | 15 | 2021 | 253789 | 0.14 | Why? |
| Genetic Techniques | 1 | 2014 | 79 | 0.14 | Why? |
| Interferon-beta | 1 | 2020 | 979 | 0.13 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.12 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.12 | Why? |
| Toll-Like Receptor 3 | 1 | 2015 | 391 | 0.12 | Why? |
| Interferon Regulatory Factor-3 | 1 | 2014 | 379 | 0.12 | Why? |
| Acute Lung Injury | 1 | 2020 | 904 | 0.12 | Why? |
| Immunity, Innate | 3 | 2021 | 6570 | 0.11 | Why? |
| Nanoparticles | 2 | 2021 | 2040 | 0.11 | Why? |
| Coronavirus | 3 | 2018 | 18339 | 0.11 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 5 | 2021 | 8843 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.11 | Why? |
| Betacoronavirus | 9 | 2021 | 204454 | 0.11 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.11 | Why? |
| Vero Cells | 7 | 2020 | 14117 | 0.11 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.11 | Why? |
| Respiratory System | 2 | 2020 | 3213 | 0.10 | Why? |
| Severe Acute Respiratory Syndrome | 5 | 2021 | 12361 | 0.10 | Why? |
| Pneumonia, Viral | 10 | 2021 | 243684 | 0.09 | Why? |
| Mice, Knockout | 3 | 2020 | 1815 | 0.09 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2013 | 482 | 0.09 | Why? |
| Gene Regulatory Networks | 1 | 2013 | 820 | 0.08 | Why? |
| Chiroptera | 2 | 2021 | 3530 | 0.08 | Why? |
| Transcription, Genetic | 1 | 2013 | 1326 | 0.08 | Why? |
| Influenza A virus | 2 | 2020 | 2234 | 0.08 | Why? |
| Clinical Trials, Phase III as Topic | 2 | 2021 | 782 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.08 | Why? |
| Cysteine Endopeptidases | 1 | 2014 | 1557 | 0.07 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.07 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.07 | Why? |
| Mice, Inbred C57BL | 3 | 2021 | 5542 | 0.07 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.07 | Why? |
| Toll-Like Receptor 4 | 2 | 2020 | 390 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Chromatin Immunoprecipitation | 2 | 2014 | 53 | 0.07 | Why? |
| Female | 20 | 2021 | 380317 | 0.07 | Why? |
| Viral Load | 6 | 2021 | 15850 | 0.07 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.06 | Why? |
| Histones | 2 | 2018 | 371 | 0.06 | Why? |
| Mice, Transgenic | 2 | 2020 | 2739 | 0.06 | Why? |
| Virulence | 2 | 2020 | 2172 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Lung | 9 | 2021 | 31049 | 0.06 | Why? |
| Cytokines | 5 | 2021 | 15010 | 0.06 | Why? |
| Respiratory Mucosa | 2 | 2020 | 1522 | 0.06 | Why? |
| Vaccines, Live, Unattenuated | 1 | 2020 | 28 | 0.06 | Why? |
| Pre-Exposure Prophylaxis | 2 | 2021 | 1138 | 0.06 | Why? |
| Asparagine | 1 | 2020 | 83 | 0.06 | Why? |
| Humans | 27 | 2021 | 930598 | 0.06 | Why? |
| Gene Expression Regulation | 1 | 2014 | 4020 | 0.06 | Why? |
| Macaca nemestrina | 1 | 2020 | 71 | 0.05 | Why? |
| Heterografts | 1 | 2021 | 203 | 0.05 | Why? |
| DNA, Recombinant | 1 | 2020 | 94 | 0.05 | Why? |
| Immunity, Heterologous | 1 | 2021 | 129 | 0.05 | Why? |
| Carboxylesterase | 1 | 2020 | 22 | 0.05 | Why? |
| Haplorhini | 1 | 2021 | 307 | 0.05 | Why? |
| Binding, Competitive | 1 | 2020 | 264 | 0.05 | Why? |
| Tissue Culture Techniques | 1 | 2020 | 158 | 0.05 | Why? |
| THP-1 Cells | 1 | 2021 | 374 | 0.05 | Why? |
| Receptors, Fc | 1 | 2021 | 153 | 0.05 | Why? |
| RNA, Guide | 1 | 2021 | 269 | 0.05 | Why? |
| Proteomics | 3 | 2018 | 2481 | 0.05 | Why? |
| Signal Transduction | 2 | 2015 | 7207 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Forkhead Transcription Factors | 1 | 2020 | 231 | 0.05 | Why? |
| Glycine | 1 | 2020 | 203 | 0.05 | Why? |
| Mutation | 4 | 2020 | 12376 | 0.05 | Why? |
| Phagocytosis | 1 | 2021 | 409 | 0.05 | Why? |
| Liposomes | 1 | 2021 | 334 | 0.05 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 4 | 2020 | 9659 | 0.05 | Why? |
| Cross Protection | 1 | 2021 | 373 | 0.05 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 349 | 0.05 | Why? |
| Genetic Fitness | 1 | 2020 | 339 | 0.05 | Why? |
| Primary Cell Culture | 1 | 2020 | 501 | 0.05 | Why? |
| West Nile virus | 1 | 2020 | 206 | 0.05 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.04 | Why? |
| Major Histocompatibility Complex | 1 | 2018 | 70 | 0.04 | Why? |
| Phenotype | 2 | 2021 | 4037 | 0.04 | Why? |
| West Nile Fever | 1 | 2020 | 166 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2020 | 800 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2021 | 801 | 0.04 | Why? |
| Protein Engineering | 1 | 2021 | 536 | 0.04 | Why? |
| Receptors, IgG | 1 | 2021 | 578 | 0.04 | Why? |
| Random Allocation | 1 | 2020 | 773 | 0.04 | Why? |
| Chromosome Mapping | 1 | 2017 | 178 | 0.04 | Why? |
| Antibiotic Prophylaxis | 1 | 2020 | 399 | 0.04 | Why? |
| Antigenic Variation | 1 | 2018 | 249 | 0.04 | Why? |
| HEK293 Cells | 2 | 2020 | 8394 | 0.04 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.04 | Why? |
| Post-Exposure Prophylaxis | 1 | 2021 | 472 | 0.04 | Why? |
| Species Specificity | 1 | 2020 | 1356 | 0.04 | Why? |
| Chemoprevention | 1 | 2021 | 585 | 0.04 | Why? |
| Recombinant Fusion Proteins | 1 | 2021 | 919 | 0.04 | Why? |
| Epitope Mapping | 1 | 2021 | 1240 | 0.04 | Why? |
| Models, Molecular | 2 | 2020 | 7616 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2020 | 1132 | 0.04 | Why? |
| Viral Proteins | 1 | 2014 | 7370 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2018 | 640 | 0.04 | Why? |
| Quantitative Trait Loci | 1 | 2017 | 340 | 0.04 | Why? |
| Receptors, Interleukin | 1 | 2015 | 83 | 0.04 | Why? |
| Electrophoretic Mobility Shift Assay | 1 | 2014 | 56 | 0.04 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.04 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.04 | Why? |
| Epithelial Cells | 2 | 2021 | 3508 | 0.04 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.04 | Why? |
| Weight Loss | 1 | 2021 | 826 | 0.04 | Why? |
| Interferon Type I | 2 | 2021 | 2789 | 0.03 | Why? |
| Adenoviridae | 1 | 2020 | 1151 | 0.03 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.03 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| Immunization, Passive | 2 | 2020 | 10067 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.03 | Why? |
| Male | 11 | 2021 | 367725 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2020 | 1706 | 0.03 | Why? |
| Administration, Oral | 1 | 2021 | 2340 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2020 | 1083 | 0.03 | Why? |
| Aging | 2 | 2020 | 3581 | 0.03 | Why? |
| Furin | 1 | 2020 | 1054 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.03 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.03 | Why? |
| Active Transport, Cell Nucleus | 1 | 2013 | 203 | 0.03 | Why? |
| Ubiquitin | 1 | 2014 | 243 | 0.03 | Why? |
| Orthomyxoviridae Infections | 1 | 2020 | 1001 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| RNA | 1 | 2020 | 1278 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.03 | Why? |
| Interferon-alpha | 1 | 2020 | 1442 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Transfection | 1 | 2014 | 864 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Microarray Analysis | 1 | 2013 | 262 | 0.03 | Why? |
| Open Reading Frames | 1 | 2018 | 1898 | 0.03 | Why? |
| Lung Injury | 1 | 2020 | 919 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Cystic Fibrosis | 1 | 2020 | 1104 | 0.03 | Why? |
| Oropharynx | 1 | 2018 | 1581 | 0.03 | Why? |
| Macaca mulatta | 1 | 2020 | 3716 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.02 | Why? |
| Lung Transplantation | 1 | 2021 | 1554 | 0.02 | Why? |
| Body Weight | 1 | 2015 | 1074 | 0.02 | Why? |
| Transcription Factors | 1 | 2014 | 784 | 0.02 | Why? |
| DNA Primers | 1 | 2013 | 1170 | 0.02 | Why? |
| Respiratory Function Tests | 1 | 2015 | 1755 | 0.02 | Why? |
| RNA, Viral | 3 | 2020 | 32276 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Cluster Analysis | 1 | 2014 | 3001 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.02 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2014 | 3788 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Disease Susceptibility | 1 | 2015 | 4002 | 0.01 | Why? |
| Survival Analysis | 1 | 2015 | 7592 | 0.01 | Why? |
| Middle Aged | 3 | 2020 | 270681 | 0.01 | Why? |
| Computational Biology | 1 | 2013 | 4514 | 0.01 | Why? |
| Protein Binding | 1 | 2014 | 11430 | 0.01 | Why? |
| Models, Biological | 1 | 2014 | 4907 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Viral Nonstructural Proteins | 1 | 2014 | 4810 | 0.01 | Why? |
| Aged | 2 | 2020 | 215776 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 11367 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Adult | 1 | 2020 | 244371 | 0.00 | Why? |
Schäfer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(216)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(437)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_